| Alaina Danielle Odom, CRNP | |
|
1022 1st St N Ste 220, Alabaster, AL 35007-8759 | |
| (205) 663-1023 | |
| Not Available |
| Full Name | Alaina Danielle Odom |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1022 1st St N Ste 220, Alabaster, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902307978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 1-140574 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Shelby Baptist Medical Center | Alabaster, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastroenterology Associates Of North-central Alabama Inc | 3072591478 | 77 |
News Archive
Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits.
Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX and VISTABEL (Allergan's botulinum toxin type A products).
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL).
Claims about the health benefits of foods and nutritional supplements have proliferated in recent years, most of them based on studies measuring ingredients' effects on biomarkers as substitutes for actual clinical outcomes.
"The number of U.S. physicians and other medical professionals prescribing electronically is expected to more than double this year, enticed by higher Medicare payments tied to the technology's use," Dow Jones Newswires/Wall Street Journal reports.
› Verified 8 days ago
| Entity Name | Gastroenterology Associates Of North-central Alabama Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528080595 PECOS PAC ID: 3072591478 Enrollment ID: O20040712001151 |
News Archive
Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits.
Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX and VISTABEL (Allergan's botulinum toxin type A products).
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL).
Claims about the health benefits of foods and nutritional supplements have proliferated in recent years, most of them based on studies measuring ingredients' effects on biomarkers as substitutes for actual clinical outcomes.
"The number of U.S. physicians and other medical professionals prescribing electronically is expected to more than double this year, enticed by higher Medicare payments tied to the technology's use," Dow Jones Newswires/Wall Street Journal reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alaina Danielle Odom, CRNP 513 Brookwood Blvd Ste 401, Birmingham, AL 35209-6883 Ph: () - | Alaina Danielle Odom, CRNP 1022 1st St N Ste 220, Alabaster, AL 35007-8759 Ph: (205) 663-1023 |
News Archive
Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits.
Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX and VISTABEL (Allergan's botulinum toxin type A products).
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL).
Claims about the health benefits of foods and nutritional supplements have proliferated in recent years, most of them based on studies measuring ingredients' effects on biomarkers as substitutes for actual clinical outcomes.
"The number of U.S. physicians and other medical professionals prescribing electronically is expected to more than double this year, enticed by higher Medicare payments tied to the technology's use," Dow Jones Newswires/Wall Street Journal reports.
› Verified 8 days ago
Stephanie Lynn Woods, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 205-620-7059 | |
Jenifer Justice, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 145 Sundance, Alabaster, AL 35007 Phone: 662-640-8804 | |
Mrs. Amanda T Cabaniss, RN, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1024 1st St N, Central Alabama Oncology, Llc, Alabaster, AL 35007 Phone: 205-664-4051 Fax: 205-664-4054 | |
Brody Weldon, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 205-620-7004 | |
Mr. Ricardo Paitz, ACNPC-AG Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1000 1st St N, Alabaster, AL 35007 Phone: 205-620-8100 | |
Jennifer Gafnea, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 1st St N Ste C, Alabaster, AL 35007 Phone: 205-381-2381 | |
William Alexander Woodard, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 1st Street North Ste. C, Alabaster, AL 35007 Phone: 205-663-5990 |